126 related articles for article (PubMed ID: 9463877)
1. Development of high-activity 252Cf sources for neutron brachytherapy.
Martin RC; Laxson RR; Miller JH; Wierzbicki JG; Rivard MJ; Marsh DL
Appl Radiat Isot; 1997; 48(10-12):1567-70. PubMed ID: 9463877
[TBL] [Abstract][Full Text] [Related]
2. Clinical brachytherapy with neutron emitting 252Cf sources and adherence to AAPM TG-43 dosimetry protocol.
Rivard MJ; Wierzbicki JG; Van den Heuvel F; Martin RC; McMahon RR
Med Phys; 1999 Jan; 26(1):87-96. PubMed ID: 9949403
[TBL] [Abstract][Full Text] [Related]
3. Production, distribution and applications of californium-252 neutron sources.
Martin RC; Knauer JB; Balo PA
Appl Radiat Isot; 2000; 53(4-5):785-92. PubMed ID: 11003521
[TBL] [Abstract][Full Text] [Related]
4. [The CT-stereotaxic neutron brachytherapy of brain tumors with californium sources on the ANET-B apparatus].
Melikian AG; Liass FM; Shkol'nik FG; Chekhonadskiĭ VN; Elisiutin GP; Golanov AV; Kachkov IA; Borodkin SM; Lobanov SA; Spasokukotskaia ON
Zh Vopr Neirokhir Im N N Burdenko; 1992; (2-3):15-21. PubMed ID: 1326193
[TBL] [Abstract][Full Text] [Related]
5. Experimental determination of the thermal neutron flux around two different types of high intensity 252Cf sources.
Schmidt B; Maughan RL; Yudelev M; Kota C; Wanwilairat S
Med Phys; 1999 Jan; 26(1):83-6. PubMed ID: 9949402
[TBL] [Abstract][Full Text] [Related]
6. Dosimetry for 252Cf neutron emitting brachytherapy sources: protocol, measurements, and calculations.
Rivard MJ
Med Phys; 1999 Aug; 26(8):1503-14. PubMed ID: 10501050
[TBL] [Abstract][Full Text] [Related]
7. Remote afterloading for neutron brachytherapy using californium-252.
Tacev T; Grigorov G; Papírek T; Kolarík V
Strahlenther Onkol; 2003 Feb; 179(2):113-7. PubMed ID: 12590322
[TBL] [Abstract][Full Text] [Related]
8. Measurements and calculations of thermal neutron fluence rate and neutron energy spectra resulting from moderation of 252Cf fast neutrons: applications for neutron capture therapy.
Rivard MJ
Med Phys; 2000 Aug; 27(8):1761-9. PubMed ID: 10984222
[TBL] [Abstract][Full Text] [Related]
9. [Interstitial neutron therapy using flexible 252Cf sources].
Vtiurin BM; Medvedev VS; Ivanov VN; Elisiutin GP; Petrovskaia GA
Med Radiol (Mosk); 1984 Jun; 29(6):7-16. PubMed ID: 6738328
[TBL] [Abstract][Full Text] [Related]
10. Measurement of augmentation of 252Cf implant by 10B and 157Gd neutron capture.
Wierzbicki JG; Maruyama Y; Porter AT
Med Phys; 1994 Jun; 21(6):787-90. PubMed ID: 7935215
[TBL] [Abstract][Full Text] [Related]
11. Neutron dosimetry for a general 252Cf brachytherapy source.
Rivard MJ
Med Phys; 2000 Dec; 27(12):2803-15. PubMed ID: 11190964
[TBL] [Abstract][Full Text] [Related]
12. Californium-252 interstitial implants in carcinoma of the tongue.
Vtyurin BM; Ivanov VN; Medvedev VS; Galantseva GF; Abdulkadyrov SA; Ivanova LF; Petrovskaya GA; Plichko VI
Int J Radiat Oncol Biol Phys; 1985 Mar; 11(3):441-9. PubMed ID: 3972658
[TBL] [Abstract][Full Text] [Related]
13. Boron neutron capture enhancement of 252Cf brachytherapy.
Beach JL; Schroy CB; Ashtari M; Harris MR; Maruyama Y
Int J Radiat Oncol Biol Phys; 1990 Jun; 18(6):1421-7. PubMed ID: 2370192
[TBL] [Abstract][Full Text] [Related]
14. Dosimetry of 252Cf sources for neutron radiotherapy with and without augmentation by boron neutron capture therapy.
Yanch JC; Zamenhof RG
Radiat Res; 1992 Sep; 131(3):249-56. PubMed ID: 1438684
[TBL] [Abstract][Full Text] [Related]
15. A feasibility study of 252Cf neutron brachytherapy, cisplatin + 5-FU chemo-adjuvant and accelerated hyperfractionated radiotherapy for advanced cervical cancer.
Maruyama Y; Bowen MG; Van Nagell JR; Gallion HH; DePriest P; Wierzbicki J
Int J Radiat Oncol Biol Phys; 1994 Jun; 29(3):529-34. PubMed ID: 8005811
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of brachytherapy with californium-252 neutrons versus cesium-137 photons for eradication of bulky localized cervical cancer: single-institution study.
Maruyama Y; van Nagell JR; Yoneda J; Donaldson E; Gallion H; Higgins R; Powell D; Turner C; Kryscio R
J Natl Cancer Inst; 1988 Jun; 80(7):501-6. PubMed ID: 3367388
[TBL] [Abstract][Full Text] [Related]
17. A comparison of the expected costs of high dose rate brachytherapy using 252Cf versus 192Ir.
Rivard MJ; Kirk BL; Stapleford LJ; Wazer DE
Appl Radiat Isot; 2004 Dec; 61(6):1211-6. PubMed ID: 15388112
[TBL] [Abstract][Full Text] [Related]
18. [Contact neutron therapy of tumors with 252Cf irradiation].
Vtiurin BM
Med Radiol (Mosk); 1987 Sep; 32(9):62-7. PubMed ID: 3657457
[TBL] [Abstract][Full Text] [Related]
19. A radiobiological model for the relative biological effectiveness of high-dose-rate 252Cf brachytherapy.
Rivard MJ; Melhus CS; Zinkin HD; Stapleford LJ; Evans KE; Wazer DE; Odlozilíková A
Radiat Res; 2005 Sep; 164(3):319-23. PubMed ID: 16137205
[TBL] [Abstract][Full Text] [Related]
20. A phase I trial of neutron brachytherapy for the treatment of malignant gliomas.
Patchell RA; Yaes RJ; Beach L; Kryscio RJ; Davis DG; Tibbs PA; Young B
Br J Radiol; 1997 Nov; 70(839):1162-8. PubMed ID: 9536908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
